摘要
目的:探讨经尿道前列腺汽化电切术治疗高龄非肌层浸润性膀胱癌合并前列腺增生的临床效果及安全性。方法:选择2016年1月-2017年1月笔者所在医院收治的40例高龄非肌层浸润性膀胱癌合并前列腺增生患者为观察对象,均接受经尿道前列腺汽化电切术治疗,观察临床治疗安全性和有效性。结果:40例均顺利完成手术,平均手术时间为(51.5±11.3)min,平均术中出血量为(186.1±15.3)ml,均无手术并发症。随访1年,复发率为10%。随访1年后,患者IPSS评分明显低于术前,QOL评分明显高于术前,Qmax明显大于术前,PRV明显少于术前(P<0.05)。结论:高龄非肌层浸润性膀胱癌合并前列腺增生患者接受经尿道前列腺汽化电切术治疗,有效性和安全性均较高,具有推广和应用价值。
Objective:To investigate the clinical effect and safety of transurethral electrovaporization of prostate in the treatment of non muscular invasive bladder cancer with prostatic hyperplasia in the elderly.Method:From January 2016 to January 2017,40 elderly patients with non muscular invasive bladder cancer with prostatic hyperplasia were selected as the observation objects.All patients were treated with transurethral electrovaporization of prostate,and the safety and effectiveness of clinical treatment were observed.Result:All the 40 cases successfully completed the operation,and the average operation time was(51.5±11.3)min,the average intraoperative hemorrhage was(186.1±15.3)ml,and there were no complications.Follow-up for one year,the recurrence rate was 10%.After 1 year of follow-up,IPSS score was significantly lower than that before operation,and QOL score was significantly higher than that before operation,Qmax was significantly higher than that before operation,and PRV was significantly less than that before operation(P<0.05).Conclusion:Transurethral electrovaporization of prostate is an effective and safe method for the treatment of non muscle invasive bladder cancer with prostatic hyperplasia in the elderly,and has the value of popularization and application.
作者
林华
严吕霞
LIN Hua;YAN Lüxia(Xiantao First People’s Hospital,Xiantao 433000,China)
出处
《中外医学研究》
2020年第5期119-120,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
经尿道前列腺汽化电切术
高龄
非肌层浸润性膀胱癌
前列腺增生
安全性
Transurethral electrovaporization of prostate
Elderly
Non muscular invasive bladder cancer
Prostatic hyperplasia
Safety